medigraphic.com
SPANISH

Correo Científico Médico de Holguín

ISSN 1560-4381 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2017, Number 4

<< Back Next >>

Correo Científico Médico 2017; 21 (4)

Elimination of Typhoid Fever in Holguín. An achievement of cuban Medicine. 1972-2016

Escobar PME, Ricardo PO, Pupo ZA, Gallegos BG, Agüero UA, Gandarilla RL
Full text How to cite this article

Language: Spanish
References: 0
Page: 979-989
PDF size: 304.32 Kb.


Key words:

typhoid fever, morbility, mortality, reactogenicity, vaccines.

ABSTRACT

Introduction: typhoid fever is a systemic infection caused by Salmonella tiphy through ingestion of contaminated food (fecal-oral). It is a public health problem, especially in developing country.
Objective: to characterize typhoid fever in Holguin province during the years 1972-2016.
Method: a longitudinal descriptive study of series of reported cases of typhoid by EDO card (Notifiable Diseases) in Holguin province since 1972 to 2016, in order to characterize the typhoid in Holguin province was conducted. The universe consisted of 471 patients reported for typhoid Fever, according to EDO card.
Results: no deaths were reported since 1974, children under 15 were the most affected, the Holguin municipality remained as high risk. The application of the Vi much less reactogenic and more effective polysaccharide Cuban vaccine used previously heat-phenol, may be the cause or part of the cause for the non-occurrence of cases in the last 10 years in the province.
Conclusions: the morbidity due to typhoid fever has decreased as well as the number of outbreaks and affected in outbreaks. The immediate control measures and the existence of a control program, in addition to the new vaccine of national production, manufactured by the Finlay laboratories, have made such achievements possible.





2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Correo Científico Médico. 2017;21